A Phase 2 Study of IkT-001Pro in Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT06643143 · WITHDRAWN

Trial details

NCT number: NCT06643143
Sponsor: Inhibikase Therapeutics
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)

Start date: 2025-06-30
Primary completion: 2027-06-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.